Suggestions
Yong-Mo Ahn
Research Associate at Rutgers New Jersey Medical School
Yong-Mo Ahn is a research scientist with expertise in tuberculosis drug discovery and development. He has held several positions in academic and government research institutions:
Career Path
Ahn previously worked as a senior research scientist in Dr. Joel S. Freundlich's laboratory at Rutgers New Jersey Medical School from April 2019 to February 2022.34 In this role, he spent 2 years and 11 months as a Senior Researcher at Rutgers.4
Currently, Ahn is employed as a Scientist at the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health.23
Research Focus
Ahn's work primarily centers on tuberculosis research. He has been involved in projects related to:
- Chemical biology
- Medicinal chemistry
- Host-pathogen interactions
- Experimental chemotherapy using animal models
- Clinical studies in tuberculosis patients
His research aims to improve chemotherapy treatments for tuberculosis, particularly for drug-resistant strains.1
Collaborations and Achievements
Ahn has collaborated with prominent research groups in the field of tuberculosis, including the Tuberculosis Research Section (TBRS) led by Dr. Clifton Barry.15 This group is known for its significant contributions to TB drug discovery and development, including the discovery of Pretomanid, an FDA-approved treatment for multidrug-resistant tuberculosis.1
Yong-Mo Ahn's work contributes to the broader efforts of improving treatments for tuberculosis patients and advancing our understanding of the disease through various scientific approaches.
